Although anogenital lichen sclerosus (ALS), an inflammatory dermatosis that affects the anogenital region, mainly affects postmenopausal women, 15% of cases are diagnosed before puberty.
SM-020 is under clinical development by DermBiont and currently in Phase II for Dermatosis. According to GlobalData, Phase II drugs for Dermatosis does not have sufficient historical data to build an ...